Rimm Lab Validates Objective Prognostic Marker in Patients With Early-stage Melanoma
An objective assessment of automated electronic tumor infiltrating lymphocytes percentage (eTILs%) scores is a strong prognostic marker in patients with early-stage melanoma. The study also identifies distinct TIL subpopulations that carry the prognostic values.
Dhanpat Jain, MD, Appointed to Cancer Committee of College of American Pathologists
Dhanpat Jain, MD, Professor of Pathology and of Medicine (Digestive Diseases), has been named to the Cancer Committee of the College of American Pathologists (CAP), the leading organization of board-certified pathologists that fosters and advocates excellence in the practice of pathology and laboratory medicine worldwide.
American Society for Investigative Pathology to Honor Qin Yan, PhD, with 2023 Outstanding Investigator Award
The American Society for Investigative Pathology has announced it will honor Qin Yan, PhD, Associate Professor of Pathology at Yale School of Medicine, with its 2023 Outstanding Investigator Award.
Manju Prasad, MD, MBBS, on Head and Neck Cancer Awareness Month
In recognition of Head and Neck Cancer Awareness Month, Manju Prasad, MD, MBBS, Professor of Pathology; Director, Endocrine Head and Neck Pathology Fellowship Program; Director, Endocrine Head and Neck Pathology, provides her insight.
Three Yale Cancer Center Trainees Receive Travel Awards to AACR Annual Meeting
The American Association for Cancer Research recently announced awards to support three young scientists from Yale Cancer Center to attend the 2022 Annual Meeting of the American Association for Cancer Research (AACR) in New Orleans from April 8 to 13.
Adebowale Adeniran, MD, on Kidney Cancer Awareness Month
In recognition of Kidney Cancer Awareness Month, Adebowale Adeniran, MD, Professor of Pathology; Director of Cytopathology; Director, Cytology Laboratory; Director, Anatomic Pathology Elective Program in Pathology, explains how Yale Pathologists work with Smilow Cancer Hospital oncologists to enhance patient care and provide the best course of treatment.
Joanna Gibson, MD, PhD, on Colorectal Cancer Awareness Month
In recognition of Colorectal Cancer Awareness Month, Joanna Gibson, MD, PhD, Associate Professor of Pathology and Director of Quality and Patient Safety at Yale Pathology, explains how Yale Pathologists collaborate with Smilow Cancer Hospital oncologists to determine the best therapeutic course for patients.
Dr. Aileen Fernandez Discusses Diversity Equity, and Inclusion with Shirley Malcolm of the American Association for the Advancement of Science
Aileen Fernandez, PhD, a Postdoctoral Fellow in the Department of Pathology at Yale School of Medicine, speaks with Shirley Malcolm, PhD, Senior Advisor to the Director of the American Association for the Advancement of Science and Director of its SEA Change initiative, which aims to advance institutional transformation in support of diversity, equity and inclusion, especially in colleges and universities.Source: YouTube
Officials Commend Partnership Among Yale Pathology, Yale School of Public Health and State Health Department to Expand SalivaDirect™ Testing at 2 New Haven Sites
Officials from the Yale Department of Pathology, the Yale School of Public Health and the Yale School of Medicine, along with Congresswoman Rosa DeLauro and Lt. Gov. Susan Bysiewicz, held a press conference Jan. 27 in New Haven’s Long Wharf to mark the opening of two free COVID-19 testing sites.
Chen Liu, MD, PhD, Leads Effort to Establish Institutional Biorepository at Yale School of Medicine
Chen Liu, MD, PhD, Chair of Yale Pathology, is leading an effort at Yale School of Medicine to establish an institutional biorepository for the coordinated collection of tissue, plasma, serum, and genetic samples, and clinical data using common processes and information systems.
Sanja Dacic, MD, PhD, Appointed Vice Chair and Director of Anatomic Pathology at Yale Pathology
Sanja Dacic, MD, PhD, an internationally renowned and highly accomplished leader in anatomic pathology, has been appointed Vice Chair and Director of Anatomic Pathology in the Department of Pathology at Yale School of Medicine, effective May 1, 2022.
Standard IHC Assays Show Poor Accuracy in Identifying Low HER2 Expression in Breast Cancer;
Survey data collected from more than 1400 laboratories around the world have demonstrated poor agreement in the evaluation of patients with breast cancer who have a low HER2 immunohistochemistry (IHC) score of 0 or 1+ using standard HER2 assays, according to findings from an analysis presented during the 2021 San Antonio Breast Cancer Symposium. “The scoring accuracy for HER2 IHC in the low range [0 and 1+] is poor,” says lead study author Aileen Fernandez, PhD, of Yale Department of Pathology. “This inaccuracy in the real world could lead to mis-assignment of many patients for treatment with fam-trastuzumab deruxtecan-nxki [Enhertu] for [those who are] HER2 low.”Source: OncLive.com